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Abstract The complete primary structure of the peptide antibiotic AS-48 produced by Enterococcus faecalis has heen determined by chemical 
degradation analysis. The cyclic nature of this 70 residues containing peptide was demonstrated by plasma desorption mass analysis of the generated 
peptides and electrospray ionisation mass analysis of the native polypeptide. As far as we know, this is the first example of an antibiotic protein cyclised 
by a tail-head peptide bond formation and not by branching of the polypeptide side chains. 
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1. Introduction 
The AS-48 antibiotic protein from Enterococcus faecalis 
subsp. liquefaciens S-48 has a broad antimicrobial activity 
against Gram-positive and Gram-negative bacteria [ 1,2]. This 
activity is due to insertion of the polypeptide into the cytoplas- 
mic membrane of the target cell which thereby becomes perme- 
able to small molecules and starts loosing cytoplasmic material 
[3]. A similar phenomenon of cell lysis is known to occur also 
as a result of the action of bacteriocins and peptide antibiotics 
produced by lactic acid bacteria [4]. In contrast to the lantibiot- 
its such as nisin [5] and lactacin 491 [6] which contain unusual 
amino acids, the antibiotic AS-48 appears to contain no other 
than the natural amino acids as could be deduced from its 
amino acid compositional analysis [2]. Here we report the com- 
plete primary structure of the antibiotic protein, a goal which 
could only be achieved by Edman degradation analysis in com- 
bination with accurate mass analysis methods. 
polypropylene tubes and dried in a Speed Vat concentrator (Savant, 
Hicksville, USA). Prior to sequence analysis peptides were redissolved 
in 0.1% TFA/water; the remaining peptide solutions were stored at 
-18°C. 
Sequence analysis was performed on the models 477A or 476A pulsed 
liquid phase sequenators with on-line PTH-analysis on a 120A analyser 
(Applied Biosystems). Sequencing reagents and solvents were obtained 
from the same firm. 
Mass determination of the peptides was performed by plasma 
desorption mass spectrometry (PDMS) on a BIO-ION 20K time of 
flight instrument (BioIon, Uppsala, Sweden). Samples were prepared 
by adsorption on a nitrocellulose layer in a 50% MeOH/H,O solution 
for 15 min. After adsorption, the targets where dried with a N, stream. 
The applied acceleration voltage was 15 kV for 1 million counts (start 
detector). Mass determination of the complete protein was determined 
on a BIO-Q electrospray mass spectrometer (Fisons Instruments, Al- 
trincham, UK). In this case the protein was dissolved in 50% MeOH/ 
H,O, 1% acetic acid and introduced by a 10 ~1 sample loop injector in 
the ionisation chamber at a flow rate (same solvent) of 4 @/min. The 
capillary voltage was set at 4 kV, the sample cone voltage was 50 V. 
3. Results and discussion 
2. Materials and methods 
Peptide AS-48 was purified as in [2]. About 30 nmol of the AS-48 
protein were digested with Lys-C endoproteinase (Wako, Osaka, 
Japan). The digest was carried out in 100 mM Tris-HCl buffer, pH 8.0, 
using an E(nzyme)lS(ubstrate) ratio of l/30, during 12 h at 37°C. A 
second digest, on the same amount, was performed using the endopro- 
teinase Glu-C isolated from Staphylococcus aureus strain V8 (Miles, 
Slough, UK); E/S was 1130 in 20 mM NaH,PQ,, pH 7, and the incuba- 
tion 5 h at 37°C. A final digest, with chymotrypsine (Worthington, 
Freehold, NY), was then performed (30 nmol AS-48, E/S = 1130) in 100 
mM NH,HCO,~ pH 8.0, for 4 h at 37’C. 
The peptides resulting from these digests were subjected to reversed- 
phase high-performance liquid chromatography on a FTC Cl8 column 
(2.1 x 220 mm, 5 pm) (Brownlee, Applied Biosystems, Foster City, 
USA). The gradient was formed with a 140A solvent delivery system 
(Applied Biosystems). The composition of solvent A was 0.1% tri- 
fluoroacetic acid (TFA) in Milli Q water (Millipore, Bedford, USA); 
solvent B was 0.1% TFA in 70% acetonitrile/water. Detection of the 
peptides was done with a diode array detector (Model lOOOS, Applied 
Biosystems) and the absorbance at 220 nm registered on a chart 
recorder (speed: 0.5 cm/min). Fractions were collected manually in 
*Corresponding author. Fax: (32) (9) 264 5338. 
3. I. Sequence analysis 
The primary structure determination of the AS-48 protein 
encountered the initial difficulty to be not susceptible to Edman 
degradation, suggesting that the N-terminal residue was 
blocked. Also treatment with carboxypeptidases A and B did 
not cleave off any C-terminal residues (results not shown). A 
first digest, with endoproteinase Lys-C, revealed only four pep- 
tides of relatively short length, two of which (K3 and K4) had 
the same sequence containing a tryptophan residue at Edman- 
cycle 6. The position of this residue is shown as the last residue 
in Fig. 1. Since some large peptides were apparently lost on the 
C 18 column during separation, a second Lys-C digest was per- 
formed and the resulting peptide mixture was subjected to se- 
quence analysis without separation. Apart from the sequences 
already known, this mixture revealed the sequence of a region 
covering 49 residues (G1u4-Lys”) which could be identified as 
a single polypeptide from Edmancycle 10 onwards. The hydro- 
phobic nature of this region explains why the peptide remained 
adsorbed to the Cl8 reversed phase column using the elution 
conditions described in section 2. 
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Fig. 1 The complete amino acid sequence of peptide antibiotic AS-48. Because of the cyclic nature of the structure the position numbers of the amino 
acids are indicated between brackets. Ch, K en S represent peptides obtained by chymotrypsin, Lys C and Glu-C protease digestion, respectively, 
K-m is the peptide mixture obtained after the second Lys-C protease digest. The arrows indicate the PTH-derivatives of the amino acids un- 
ambiguously determined by sequence analysis. Only these peptides are shown which are considered essential for deducing the sequence. 
A second digest, envisaged by the presence of a Glu-residue 
at position 20, was performed using endoproteinase Glu-C 
(Fig. 2A). Some peptides, S2, S4, S6a and S7d, were found to 
cover the assumed C-terminal region of the protein deduced 
from the gene sequence [7]. The sequence of the peptides S6a 
and S7d, however, did not end at the assumed C-terminal res- 
idue Trp” but continued at the assumed N-terminal sequence 
as found in the sequence analyses of peptides K3 and K4. Other 
peptides, S6b, S6c and S’la,b,c covered the N-terminal region. 
Several aspecific cleavages were found: peptide S2 ends with a 
Tyr residue, peptide S6b starts after an Ala residue. This resi- 
due is also one of the three C-terminal residues of the 
C-terminal ragged peptide S7. Again, also in this digest, no 
peptides covering the hydrophobic sequence in the middle of 
the protein could be recovered from the RPLC-column. 
To determine the complete sequence, a third digest, with the 
less specific protease chymotrypsine was performed. Separa- 
tion of the peptides yielded a large number of smaller fragments 
(Fig. 2B). Sequence analysis of these fragments confirmed the 
sequence deduced from the gene [7] and also covered the hydro- 
phobic region of the AS-48 protein. The necessary overlaps 
between the Lys-C and Glu-C peptides were detected so that 
the complete sequence of the AS-48 protein was thereby un- 
ambiguously determined. 
3.2. Mass analysis 
The obtained sequence was verified by determination of the 
molecular weight of the separated peptides by plasma desorp- 
tion mass spectrometry. This method, in which the molecular 
ions are analysed by a time of flight technique, is known to have 
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an accuracy of 0.1% for peptides with a molecular weight below 
5,000 Da [8]. The results of the mass analyses, given in 
Table 1, confirmed the results obtained by the sequence deter- 
mination. Peptides K3, S5 and Ch3 all yielded an experimental 
mass of approximately 16 atomic mass units (amu) higher than 
the value calculated from the sequence. Since these peptides 
only have three residues in common, (M l-K3), we propose that 
this difference is due to a partial oxidation of the Met’ residue. 
The non-oxidised form of these peptides was also found in 
respectively K4, S6a and Ch6a. The masses of the peptides K3, 
K4, S5, S6a and S7d, which link the C-terminal residue, Trp”, 
to the N-terminal residue Met’ all correspond to the calculated 
mass based on the sequence. Since the mass calculations of 
these peptides suggested the formation of a normal peptide 
bond and because the sequencer took the formed link without 
any problem, we conclude that this tail-head junction is indeed 
formed by a normal peptide bond. 
The mass of the complete peptide antibiotic AS-48 was deter- 
mined by electrospray mass spectrometry, a technique known 
to have an accuracy of 0.01% [9]. The calculated mass of the 
AS-48 protein, based on the average residual mass of each 
amino acid, is 7,167. 58 Da. The electrospray mass spectrum, 
however, indicates three masses of 7,150.17 Da, 7,166.5 Da and 
7,182.66 Da (indicated respectively as A, B and C in Fig. 3, top). 
Table 1 
PDMS mass results for peptides obtained by digesting the AS-48 pro- 
tein with Lys-C protease (K), Glu-C protease (S) and chymotrypsin 
(Ch) 
Peptide Sequence Mass (DA) 
Calculated Experimental 
m 
P 
f 
:: 
O L 
Kl 
K2 
K3 
K4 
Sl 
s2 
s4 
SS 
S6 (a) 
(b) 
S7 (a) 
(b) 
::; 
SlO 
Chl 
Ch2 
Ch3 
Ch4 (a) 
Ch5 (a) 
(b) 
Ch6 (a) 
(b) 
Ch8 
Ch9 (a) 
(b) 
ChlO 
Chll 
Ch12 
Ch13 -. 
E(SS)-K(60) 388.5 388.6 
A(53)-K(56) 493.6 493.1 
R(65)-K(3) 1045.3 1061.7 
R(65)-K(3) 1045.3 1045.8 
1(59)-A(69) 1211.5 1211.9 
S(50)-Y(54) 580.7 581.3 
S(50)-E(58) 1079.3 1080.0 
1(59)-E(4) 1857.3 1874.0 
1(59)-E(4) 1857.3 1860.0 
G( 13)-E(20) 830.0 n.f. 
F(5)-A( 12) 744.9 745.0 
F(5)-G(13) 801.9 801.9 
F(5)-T(14) 903.0 903.1 
V(67)-E(4) 947.2 947.9 
F(5)-N(17) 1229.4 1230.4 
L(55)-K(62) 1014.0 1014.2 
L(55)-K(60) 757.8 759.2 
M(l )-F(5) 624.8 641.9 
A(44)-Y(54) 1136.3 1137.0 
T(33)-L(40) 660.7 662.1 
A(44)-Y(54) 1136.3 1138.5 
M(l )-F(5) 624.8 626.0 
T(33)-L(40) 660.7 nf. 
K(61)-W(70) 1156.4 1157.5 
N(l7)-W(24) 830.9 831.3 
K(61)-W(70) 1156.4 1158.1 
G(63)-W(70) 900.0 900.9 
R(65)-W(70) 714.9 715.6 
G(6)-L(16) 968.2 968.7 
V(25)-L(32) 845.0 845.0 
N-terminal sequence chymotrypsin 
G(6)-L(16) 968.2 n.f. 
Ch14 
Ch15 
For the sequence-derived molecular mass calculation, the residual 
masses (monoisotopic values) of the individual amino acids were used. 
(n.f.: not found in mass spectrum). 
10 zo 
Time (minutes) 
Fig. 2 Separation by reversed phase HPLC of the peptide mixtures 
obtained after digest of AS-48 with Glu-C endoproteinase (A) and 
chymotrypsin (B) The gradient profile of solvent B is indicated by the 
diagonal ine. Numbers designate the resulting peptides. 
The lowest experimental mass value, 7,150.17 Da, corresponds 
exactly to the calculated mass value if the dehydratation of one 
water molecule, necessary for the tail-head peptide-junction 
formation, is taken into account (calculated value: 7,149.57 
Da). The second mass, 7,166.50 Da, with a mass difference of 
16.33 amu to that of peak A, represents the oxidised AS-48 
protein. A third peak, again with a mass difference of approx- 
imately 16 amu, indicates a second oxidation of the protein, 
most likely of tryptophan 70. Evidence herefore was obtained 
from the electrospray spectrum of peptide S5 which, apart from 
the mass of 1,873.26 corresponding to the oxidized peptide 
(which was also detected by PDMS) displayed an additional 
mass corresponding to an additional oxygen atom (result not 
shown). 
Analysis of a sample of AS-48 to which myoglobin 
(16,951.50 Da) has been added as an internal standard, fol- 
lowed by calculation of the masses using the MaxEnt program 
[lo] confirmed the mass differences between the species A and 
B, respectively, B and C, to be very close to 16.0 (effectively 
15.95 and 16.86; data not shown). These data exclude the pos- 
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Fig. 3 Electrospray ionisation mass spectra of native antibiotic AS-48. The top spectrum is from the sample used for sequence determination. The 
bottom spectrum is from a freshly prepared sample. The insets are the converted spectra obtained with the Transform program. 
sibility that species B would have arisen from ring opening of 
the cyclic structure during the molecular ion formation in the 
electrospray, a phenomenon which would cause a mass increase 
of 18 instead of 16 Da. 
We should also add that we very recently, after the complete 
sequence determination, measured a new sample of AS-48 
which was freshly prepared from new cells and found a mass 
of 7 149.25 Da only (Fig. 3 bottom). This sample thus represents 
the cyclic form. It underwent only minor oxidation as indicated 
by the small peaks in the spectrum. 
As far as we know, the cyclic structure of the AS48 antibiotic 
is the first example of a post-translational modification in which 
a cyclic structure arises from a ‘tail-to-head’ linkage of the gene 
product. 
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